Mahana Therapeutics is excited to announce the acquisition of CaraCare to become a global leader in the digital treatment of chronic conditions. Click here to learn more
We're empowering people with chronic conditions to lead fuller lives through our digital therapies.
Simon has over ten years of experience building world-class, mission-driven software products at scale in regulated industries. Prior to Mahana, Simon was an engineering leader at Credit Karma where he helped launch new product verticals and was a technical lead for the Hangouts project at Google. When not engineering he enjoys playing soccer, cooking, and playing with his two Goldendoodles.
Simon Levy
Co-Founder & CEO
Simon has over ten years of experience building world-class, mission-driven software products at scale in regulated industries. Prior to Mahana, Simon was an engineering leader at Credit Karma where he helped launch new product verticals and was a technical lead for the Hangouts project at Google. When not engineering he enjoys playing soccer, cooking, and playing with his two Goldendoodles.
Simon Levy
Co-Founder & CEO
Justin leads Mahana’s commercial, digital, e-commerce, product strategies, and strategic partnerships, to expand adoption of Mahana’s products, including Mahana IBS and pipeline products. He plans to implement innovative models to shape the pathway for long-term commercial success of prescription digital therapeutics. Prior to joining Mahana Therapeutics, Zamirowski served as chief commercial officer for Better Therapeutics, Inc., developing the company’s go-to-market strategies and establishing several real world evidence partnerships with world-renowned institutions to prepare the company for launching its first prescription digital therapeutic in diabetes. He has also held leading commercial and business development roles at Guidehouse, Inc., Edge Therapeutics, Otsuka, and PDL Biopharma.
Justin Zamirowski
Chief Commercial Officer
Justin leads Mahana’s commercial, digital, e-commerce, product strategies, and strategic partnerships, to expand adoption of Mahana’s products, including Mahana IBS and pipeline products. He plans to implement innovative models to shape the pathway for long-term commercial success of prescription digital therapeutics. Prior to joining Mahana Therapeutics, Zamirowski served as chief commercial officer for Better Therapeutics, Inc., developing the company’s go-to-market strategies and establishing several real world evidence partnerships with world-renowned institutions to prepare the company for launching its first prescription digital therapeutic in diabetes. He has also held leading commercial and business development roles at Guidehouse, Inc., Edge Therapeutics, Otsuka, and PDL Biopharma.
Justin Zamirowski
Chief Commercial Officer
Myla runs the finance, accounting, HR & operations infrastructure at Mahana. She came to us having guided many healthcare companies from inception to commercialization, including HealthTell, Auxogyn, Verinata Health, and ForteBio. She’s also co-founded a couple of computer peripheral startups of her own.
Myla Puyat
VP of Finance & Operations
Myla runs the finance, accounting, HR & operations infrastructure at Mahana. She came to us having guided many healthcare companies from inception to commercialization, including HealthTell, Auxogyn, Verinata Health, and ForteBio. She’s also co-founded a couple of computer peripheral startups of her own.
Myla Puyat
VP of Finance & Operations
Kendal has more than 20 years of experience in quality and regulatory with a focus on medical device, in vitro diagnostic (IVD) and clinical genomics. He has built quality and regulatory systems from the ground up at multiple startups, scaling from scratch to IPO or acquisition several times. Kendal is passionate about leading a culture of quality in startups and building cross-functional teams. During off-hours, he enjoys swimming and strategy games.
Kendal Dinsmore
VP of Global Regulatory Affairs & Quality Assurance (RA/QA)
Kendal has more than 20 years of experience in quality and regulatory with a focus on medical device, in vitro diagnostic (IVD) and clinical genomics. He has built quality and regulatory systems from the ground up at multiple startups, scaling from scratch to IPO or acquisition several times. Kendal is passionate about leading a culture of quality in startups and building cross-functional teams. During off-hours, he enjoys swimming and strategy games.
Kendal Dinsmore
VP of Global Regulatory Affairs & Quality Assurance (RA/QA)
Jon has 20 years of experience in both the pharmaceutical and business consulting industries. Having begun his career in Andersen Consulting / Accenture, he spent 10 years in senior leadership positions with responsibilities spanning multiple markets for Pfizer and Zoetis. His successes include the transition and growth of commercial operations in Northern Europe for Zoetis from IPO to Fortune 500 scale and he has run his own businesses in both UK and Chile. Jon lives in Sussex, England where he enjoys gardening with his wife, mountain biking and building Lego with his two young boys.
Jon Scholefield
VP of Business Development, Managing Director UK
Jon has 20 years of experience in both the pharmaceutical and business consulting industries. Having begun his career in Andersen Consulting / Accenture, he spent 10 years in senior leadership positions with responsibilities spanning multiple markets for Pfizer and Zoetis. His successes include the transition and growth of commercial operations in Northern Europe for Zoetis from IPO to Fortune 500 scale and he has run his own businesses in both UK and Chile. Jon lives in Sussex, England where he enjoys gardening with his wife, mountain biking and building Lego with his two young boys.
Jon Scholefield
VP of Business Development, Managing Director UK
Mahana is committed to the development of safe and effective digital therapeutics. Mahana strives to exceed customer expectations through its never-ending pursuit of quality.
Mahana defines itself by the quality of its products, enabled by the application of its quality programs and continuous improvement.
Mahana is committed to ensuring the Quality Policy and Quality Objectives are compliant with FDA 21 CFR Part 820, ISO 13485, and other applicable standards, as well as maintain the effectiveness of the Quality Management System.
If you want to make a difference in the lives of millions of people living with chronic health conditions, join us at Mahana.
Careers at Mahana
